IceCure Medical (ICCM) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.06, +1.92% vs the prior close of $1.04.
- Volume 101.37K shares, 0.6x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ICCM rises 1.9% to $1.06. Closed at $1.06, +1.92% vs the prior close of $1.04. Day range $1.03β$1.10, opened at $1.04.
ICCM daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β ICCM rises 1.9% to $1.06
- Closed at $1.06, +1.92% vs the prior close of $1.04. Day range $1.03β$1.10, opened at $1.04.
- Volume was 101.37K shares, 0.6x its 50-day average of 159.20K.
- Price is -48.1% vs its 50-day average ($2.04) and -88.1% vs its 200-day average ($8.87).
- 52-week range $0.96β$26.10; today's close sits at 0% of that range, 95.9% below the 52-week high.
Oct 15, 2026 β ICCM ends flat (+0.0%) to $1.04
- Closed at $1.04, +0.00% vs the prior close of $1.04. Day range $1.00β$1.07, opened at $1.04.
- Volume was 93.60K shares, 0.6x its 50-day average of 158.76K β lighter than usual.
- Price is -50.1% vs its 50-day average ($2.08) and -88.4% vs its 200-day average ($8.96).
- 52-week range $0.96β$26.97; today's close sits at 0% of that range, 96.1% below the 52-week high.
Oct 14, 2026 β ICCM slides 5.5% to $1.04, a 52-week low
- Closed at $1.04, -5.45% vs the prior close of $1.10. Day range $0.96β$1.09, opened at $1.09.
- Volume was 150.60K shares, 0.9x its 50-day average of 159.50K.
- Price is -51.1% vs its 50-day average ($2.13) and -88.5% vs its 200-day average ($9.05).
- 52-week range $0.96β$26.97; today's close sits at 0% of that range, 96.1% below the 52-week high.
Oct 13, 2026 β ICCM rises 1.9% to $1.10
- Closed at $1.10, +1.85% vs the prior close of $1.08. Day range $1.03β$1.13, opened at $1.11.
- Volume was 261.90K shares, 1.7x its 50-day average of 155.69K.
- Price is -49.3% vs its 50-day average ($2.17) and -88.0% vs its 200-day average ($9.15).
- 52-week range $1.03β$26.97; today's close sits at 0% of that range, 95.9% below the 52-week high.
- SEC filings that day: 6-K.
Oct 12, 2026 β ICCM dips 1.8% to $1.08, a 52-week low, 7 down days in a row
- Closed at $1.08, -1.82% vs the prior close of $1.10. Day range $1.06β$1.19, opened at $1.11.
- Volume was 78.50K shares, 0.5x its 50-day average of 155.19K β lighter than usual.
- Price is -51.0% vs its 50-day average ($2.20) and -88.3% vs its 200-day average ($9.24).
- 52-week range $1.04β$29.46; today's close sits at 0% of that range, 96.3% below the 52-week high.
- That makes 7 straight losses.
Oct 9, 2026 β ICCM dips 2.7% to $1.10, a 52-week low, 6 down days in a row
- Closed at $1.10, -2.65% vs the prior close of $1.13. Day range $1.05β$1.17, opened at $1.17.
- Volume was 124.70K shares, 0.8x its 50-day average of 153.43K.
- Price is -50.9% vs its 50-day average ($2.24) and -88.2% vs its 200-day average ($9.34).
- 52-week range $1.04β$30.30; today's close sits at 0% of that range, 96.4% below the 52-week high.
- That makes 6 straight losses.
Oct 8, 2026 β ICCM dips 1.7% to $1.13, a 52-week low on 2.2x normal volume
- Closed at $1.13, -1.74% vs the prior close of $1.15. Day range $1.04β$1.21, opened at $1.15.
- Volume was 326.80K shares, 2.2x its 50-day average of 148.82K β unusually heavy trading.
- Price is -50.3% vs its 50-day average ($2.27) and -88.0% vs its 200-day average ($9.43).
- 52-week range $1.04β$30.30; today's close sits at 0% of that range, 96.3% below the 52-week high.
- That makes 5 straight losses.
Oct 7, 2026 β ICCM slides 9.4% to $1.15, a 52-week low on 2.5x normal volume
- Closed at $1.15, -9.45% vs the prior close of $1.27. Day range $1.15β$1.30, opened at $1.29.
- Volume was 354.80K shares, 2.5x its 50-day average of 142.63K β unusually heavy trading.
- Price is -50.2% vs its 50-day average ($2.31) and -87.9% vs its 200-day average ($9.52).
- 52-week range $1.09β$30.30; today's close sits at 0% of that range, 96.2% below the 52-week high.
- That makes 4 straight losses.
Oct 6, 2026 β ICCM slides 17.5% to $1.27, a 52-week low on 4.0x normal volume
- Closed at $1.27, -17.53% vs the prior close of $1.54. Day range $1.09β$1.51, opened at $1.49.
- Volume was 533.10K shares, 4.0x its 50-day average of 133.54K β unusually heavy trading.
- Price is -45.8% vs its 50-day average ($2.34) and -86.8% vs its 200-day average ($9.62).
- 52-week range $1.09β$33.00; today's close sits at 1% of that range, 96.2% below the 52-week high.
- That makes 3 straight losses.
Oct 5, 2026 β ICCM dips 1.9% to $1.54, a 52-week low
- Closed at $1.54, -1.91% vs the prior close of $1.57. Day range $1.47β$1.61, opened at $1.59.
- Volume was 159.20K shares, 1.2x its 50-day average of 131.86K.
- Price is -35.1% vs its 50-day average ($2.37) and -84.1% vs its 200-day average ($9.71).
- 52-week range $1.47β$42.00; today's close sits at 0% of that range, 96.3% below the 52-week high.
- SEC filings that day: 6-K, 6-K.
Oct 2, 2026 β ICCM slides 7.1% to $1.57, a 52-week low on 2.4x normal volume
- Closed at $1.57, -7.10% vs the prior close of $1.69. Day range $1.55β$1.79, opened at $1.73.
- Volume was 307.40K shares, 2.4x its 50-day average of 127.66K β unusually heavy trading.
- Price is -34.7% vs its 50-day average ($2.41) and -84.0% vs its 200-day average ($9.80).
- 52-week range $1.55β$42.00; today's close sits at 0% of that range, 96.3% below the 52-week high.
ICCM latest news & SEC filings
Every SEC filing by or about ICCM in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Oct 5, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Oct 5, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Sep 28, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Sep 10, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 24, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 18, 2026 Β· Form EFFECT β EFFECT filing
EFFECT filing
Aug 18, 2026 Β· Form EFFECT β EFFECT filing
EFFECT filing
Aug 17, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 17, 2026 Β· Form 3 β New insider holdings
Initial insider ownership statement (Form 3) β a new director, officer or 10% owner disclosed their holdings
Aug 17, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 17, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 17, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 17, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 Β· Form S-8 β Employee share plan registration
Registration of shares for employee stock plans (S-8)
Things to know before you trade ICCM
- How much it moves: over the last 20 sessions the average daily move was 3.90% (largest 17.5%). That is a volatile stock.
- Liquidity: about 185.49K shares (β$196.62K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.06 vs a range of $0.96β$26.10 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:30 on Jun 4, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Oct 13, 2026; 6-K Oct 5, 2026; 6-K Oct 5, 2026.
- Listing: Nasdaq Β· industry: Surgical & Medical Instruments & Apparatus.
ICCM market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.04 | 1.10 | 1.03 | 1.06 | 101.37K |
| Oct 15, 2026 | 1.04 | 1.07 | 1.00 | 1.04 | 93.60K |
| Oct 14, 2026 | 1.09 | 1.09 | 0.96 | 1.04 | 150.60K |
| Oct 13, 2026 | 1.11 | 1.13 | 1.03 | 1.10 | 261.90K |
| Oct 12, 2026 | 1.11 | 1.19 | 1.06 | 1.08 | 78.50K |
| Oct 9, 2026 | 1.17 | 1.17 | 1.05 | 1.10 | 124.70K |
| Oct 8, 2026 | 1.15 | 1.21 | 1.04 | 1.13 | 326.80K |
| Oct 7, 2026 | 1.29 | 1.30 | 1.15 | 1.15 | 354.80K |
| Oct 6, 2026 | 1.49 | 1.51 | 1.09 | 1.27 | 533.10K |
| Oct 5, 2026 | 1.59 | 1.61 | 1.47 | 1.54 | 159.20K |
| Oct 2, 2026 | 1.73 | 1.79 | 1.55 | 1.57 | 307.40K |
| Oct 1, 2026 | 1.65 | 1.73 | 1.61 | 1.69 | 157.10K |
| Sep 30, 2026 | 1.63 | 1.82 | 1.60 | 1.62 | 320.60K |
| Sep 29, 2026 | 1.65 | 1.69 | 1.56 | 1.59 | 191.40K |
| Sep 28, 2026 | 1.71 | 1.77 | 1.60 | 1.63 | 86.90K |
| Sep 25, 2026 | 1.80 | 1.90 | 1.65 | 1.73 | 115.00K |
| Sep 24, 2026 | 1.87 | 1.94 | 1.71 | 1.73 | 90.90K |
| Sep 23, 2026 | 1.94 | 2.02 | 1.83 | 1.87 | 83.90K |
| Sep 22, 2026 | 1.98 | 2.04 | 1.94 | 1.95 | 101.10K |
| Sep 21, 2026 | 1.99 | 2.08 | 1.95 | 1.95 | 70.90K |
About IceCure Medical
IceCure Medical (ICCM) is listed on the Nasdaq and classified by the SEC under βSurgical & Medical Instruments & Apparatusβ. Its business address is in CAESAREA. State of incorporation: Israel. Fiscal year ends December 31. SEC CIK 1584371.
ICCM board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Vincent Chun Hung Chan | Director | Aug 17, 2026 |
| Yang Huang | Director | Mar 25, 2026 |
| Sharon Levita | Director | Mar 25, 2026 |
| Yonatan Malca | Director | Mar 25, 2026 |
| Ron Mayron | Director | Mar 25, 2026 |
| David Salton | Director | Aug 17, 2026 |
| Eyal Shamir | Chief Executive Officer | Mar 25, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Merav Nir Dotan | VP, Human Resources | Aug 17, 2026 |
| Shad Good | VP, Sales for North America | Aug 17, 2026 |
| Shay Levav | Chief Operating Officer | Aug 17, 2026 |
| Naum Muchnik | VP, R&D & Engineering | May 18, 2026 |
| Meir Peleg | Chief Financial Officer | Aug 17, 2026 |
| Eyal Shamir | Chief Executive Officer | Mar 25, 2026 |
| Tlalit Bussi Tel-Tzure | VP, BD & Global Marketing | Aug 17, 2026 |
| Ronen Tsimerman | Chief Financial Officer | May 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
ICCM financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $β, total liabilities $β, cash $β.
ICCM earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks Β· Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ICCM
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.